プロトンポンプ阻害剤(PPI)のグローバル市場展望 2023年-2029年:パントプラゾール、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、その他

■ 英語タイトル:Proton Pump Inhibitors (PPIs) Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート(データ管理コード:MMG23LY8614)■ 発行会社/調査会社:Market Monitor Global
■ 商品コード:MMG23LY8614
■ 発行日:2023年7月
■ 調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野:医薬品&ヘルスケア
■ ページ数:77
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[プロトンポンプ阻害剤(PPI)のグローバル市場展望 2023年-2029年:パントプラゾール、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、その他]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査レポートは次の情報を含め、世界のプロトンポンプ阻害剤(PPI)市場規模と予測を収録しています。・世界のプロトンポンプ阻害剤(PPI)市場:売上、2018年-2023年、2024年-2029年
・世界のプロトンポンプ阻害剤(PPI)市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のプロトンポンプ阻害剤(PPI)市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「パントプラゾール」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

プロトンポンプ阻害剤(PPI)のグローバル主要企業は、AstraZeneca、 Pfizer、 Janssen、 Eisai、 Eli Lilly、 Cadila Pharmaceuticals、 Santarus、 Wyeth、 Changzhou Siyao Pharmaceuticals、 Yangzhou Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、プロトンポンプ阻害剤(PPI)のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のプロトンポンプ阻害剤(PPI)市場:タイプ別、2018年-2023年、2024年-2029年
世界のプロトンポンプ阻害剤(PPI)市場:タイプ別市場シェア、2022年
・パントプラゾール、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、その他

世界のプロトンポンプ阻害剤(PPI)市場:用途別、2018年-2023年、2024年-2029年
世界のプロトンポンプ阻害剤(PPI)市場:用途別市場シェア、2022年
・病院、診療所、その他

世界のプロトンポンプ阻害剤(PPI)市場:地域・国別、2018年-2023年、2024年-2029年
世界のプロトンポンプ阻害剤(PPI)市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるプロトンポンプ阻害剤(PPI)のグローバル売上、2018年-2023年
・主要企業におけるプロトンポンプ阻害剤(PPI)のグローバル売上シェア、2022年
・主要企業におけるプロトンポンプ阻害剤(PPI)のグローバル販売量、2018年-2023年
・主要企業におけるプロトンポンプ阻害剤(PPI)のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AstraZeneca、 Pfizer、 Janssen、 Eisai、 Eli Lilly、 Cadila Pharmaceuticals、 Santarus、 Wyeth、 Changzhou Siyao Pharmaceuticals、 Yangzhou Pharmaceutical

*************************************************************

・調査・分析レポートの概要
プロトンポンプ阻害剤(PPI)市場の定義
市場セグメント
世界のプロトンポンプ阻害剤(PPI)市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のプロトンポンプ阻害剤(PPI)市場規模
世界のプロトンポンプ阻害剤(PPI)市場規模:2022年 VS 2029年
世界のプロトンポンプ阻害剤(PPI)市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのプロトンポンプ阻害剤(PPI)の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のプロトンポンプ阻害剤(PPI)製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:パントプラゾール、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、その他
プロトンポンプ阻害剤(PPI)のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、その他
プロトンポンプ阻害剤(PPI)の用途別グローバル売上・予測

・地域別市場分析
地域別プロトンポンプ阻害剤(PPI)市場規模 2022年と2029年
地域別プロトンポンプ阻害剤(PPI)売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
AstraZeneca、 Pfizer、 Janssen、 Eisai、 Eli Lilly、 Cadila Pharmaceuticals、 Santarus、 Wyeth、 Changzhou Siyao Pharmaceuticals、 Yangzhou Pharmaceutical
...

Proton-pump inhibitors (PPIs) are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production.
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization’s List of Essential Medicines.
Medically used proton pump inhibitors: Omeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.
This report aims to provide a comprehensive presentation of the global market for Proton Pump Inhibitors (PPIs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proton Pump Inhibitors (PPIs). This report contains market size and forecasts of Proton Pump Inhibitors (PPIs) in global, including the following market information:
Global Proton Pump Inhibitors (PPIs) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Proton Pump Inhibitors (PPIs) Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Proton Pump Inhibitors (PPIs) companies in 2022 (%)
The global Proton Pump Inhibitors (PPIs) market was valued at US$ 12540 million in 2022 and is projected to reach US$ 15230 million by 2029, at a CAGR of 2.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.
North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 52 per୩
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Proton Pump Inhibitors (PPIs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Proton Pump Inhibitors (PPIs) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Proton Pump Inhibitors (PPIs) Market Segment Percentages, by Type, 2022 (%)
Pantoprazole
Omeprazole
Lansoprazole
Esomeprazole
Rabeprazole
Others
Global Proton Pump Inhibitors (PPIs) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Proton Pump Inhibitors (PPIs) Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Proton Pump Inhibitors (PPIs) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Proton Pump Inhibitors (PPIs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Proton Pump Inhibitors (PPIs) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Proton Pump Inhibitors (PPIs) revenues share in global market, 2022 (%)
Key companies Proton Pump Inhibitors (PPIs) sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Proton Pump Inhibitors (PPIs) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Pfizer
Janssen
Eisai
Eli Lilly
Cadila Pharmaceuticals
Santarus
Wyeth
Changzhou Siyao Pharmaceuticals
Yangzhou Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Proton Pump Inhibitors (PPIs), market overview.
Chapter 2: Global Proton Pump Inhibitors (PPIs) market size in revenue and volume.
Chapter 3: Detailed analysis of Proton Pump Inhibitors (PPIs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Proton Pump Inhibitors (PPIs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Proton Pump Inhibitors (PPIs) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Introduction to Research & Analysis Reports
1.1 Proton Pump Inhibitors (PPIs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Proton Pump Inhibitors (PPIs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Proton Pump Inhibitors (PPIs) Overall Market Size
2.1 Global Proton Pump Inhibitors (PPIs) Market Size: 2022 VS 2029
2.2 Global Proton Pump Inhibitors (PPIs) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Proton Pump Inhibitors (PPIs) Sales: 2018-2029
3 Company Landscape
3.1 Top Proton Pump Inhibitors (PPIs) Players in Global Market
3.2 Top Global Proton Pump Inhibitors (PPIs) Companies Ranked by Revenue
3.3 Global Proton Pump Inhibitors (PPIs) Revenue by Companies
3.4 Global Proton Pump Inhibitors (PPIs) Sales by Companies
3.5 Global Proton Pump Inhibitors (PPIs) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Proton Pump Inhibitors (PPIs) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Proton Pump Inhibitors (PPIs) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Proton Pump Inhibitors (PPIs) Players in Global Market
3.8.1 List of Global Tier 1 Proton Pump Inhibitors (PPIs) Companies
3.8.2 List of Global Tier 2 and Tier 3 Proton Pump Inhibitors (PPIs) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Proton Pump Inhibitors (PPIs) Market Size Markets, 2022 & 2029
4.1.2 Pantoprazole
4.1.3 Omeprazole
4.1.4 Lansoprazole
4.1.5 Esomeprazole
4.1.6 Rabeprazole
4.1.7 Others
4.2 By Type – Global Proton Pump Inhibitors (PPIs) Revenue & Forecasts
4.2.1 By Type – Global Proton Pump Inhibitors (PPIs) Revenue, 2018-2023
4.2.2 By Type – Global Proton Pump Inhibitors (PPIs) Revenue, 2024-2029
4.2.3 By Type – Global Proton Pump Inhibitors (PPIs) Revenue Market Share, 2018-2029
4.3 By Type – Global Proton Pump Inhibitors (PPIs) Sales & Forecasts
4.3.1 By Type – Global Proton Pump Inhibitors (PPIs) Sales, 2018-2023
4.3.2 By Type – Global Proton Pump Inhibitors (PPIs) Sales, 2024-2029
4.3.3 By Type – Global Proton Pump Inhibitors (PPIs) Sales Market Share, 2018-2029
4.4 By Type – Global Proton Pump Inhibitors (PPIs) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Proton Pump Inhibitors (PPIs) Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Proton Pump Inhibitors (PPIs) Revenue & Forecasts
5.2.1 By Application – Global Proton Pump Inhibitors (PPIs) Revenue, 2018-2023
5.2.2 By Application – Global Proton Pump Inhibitors (PPIs) Revenue, 2024-2029
5.2.3 By Application – Global Proton Pump Inhibitors (PPIs) Revenue Market Share, 2018-2029
5.3 By Application – Global Proton Pump Inhibitors (PPIs) Sales & Forecasts
5.3.1 By Application – Global Proton Pump Inhibitors (PPIs) Sales, 2018-2023
5.3.2 By Application – Global Proton Pump Inhibitors (PPIs) Sales, 2024-2029
5.3.3 By Application – Global Proton Pump Inhibitors (PPIs) Sales Market Share, 2018-2029
5.4 By Application – Global Proton Pump Inhibitors (PPIs) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Proton Pump Inhibitors (PPIs) Market Size, 2022 & 2029
6.2 By Region – Global Proton Pump Inhibitors (PPIs) Revenue & Forecasts
6.2.1 By Region – Global Proton Pump Inhibitors (PPIs) Revenue, 2018-2023
6.2.2 By Region – Global Proton Pump Inhibitors (PPIs) Revenue, 2024-2029
6.2.3 By Region – Global Proton Pump Inhibitors (PPIs) Revenue Market Share, 2018-2029
6.3 By Region – Global Proton Pump Inhibitors (PPIs) Sales & Forecasts
6.3.1 By Region – Global Proton Pump Inhibitors (PPIs) Sales, 2018-2023
6.3.2 By Region – Global Proton Pump Inhibitors (PPIs) Sales, 2024-2029
6.3.3 By Region – Global Proton Pump Inhibitors (PPIs) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Proton Pump Inhibitors (PPIs) Revenue, 2018-2029
6.4.2 By Country – North America Proton Pump Inhibitors (PPIs) Sales, 2018-2029
6.4.3 US Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.4.4 Canada Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.4.5 Mexico Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Proton Pump Inhibitors (PPIs) Revenue, 2018-2029
6.5.2 By Country – Europe Proton Pump Inhibitors (PPIs) Sales, 2018-2029
6.5.3 Germany Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.5.4 France Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.5.5 U.K. Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.5.6 Italy Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.5.7 Russia Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.5.8 Nordic Countries Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.5.9 Benelux Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Proton Pump Inhibitors (PPIs) Revenue, 2018-2029
6.6.2 By Region – Asia Proton Pump Inhibitors (PPIs) Sales, 2018-2029
6.6.3 China Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.6.4 Japan Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.6.5 South Korea Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.6.6 Southeast Asia Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.6.7 India Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Proton Pump Inhibitors (PPIs) Revenue, 2018-2029
6.7.2 By Country – South America Proton Pump Inhibitors (PPIs) Sales, 2018-2029
6.7.3 Brazil Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.7.4 Argentina Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Proton Pump Inhibitors (PPIs) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Proton Pump Inhibitors (PPIs) Sales, 2018-2029
6.8.3 Turkey Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.8.4 Israel Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.8.5 Saudi Arabia Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
6.8.6 UAE Proton Pump Inhibitors (PPIs) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Proton Pump Inhibitors (PPIs) Major Product Offerings
7.1.4 AstraZeneca Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Proton Pump Inhibitors (PPIs) Major Product Offerings
7.2.4 Pfizer Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Janssen
7.3.1 Janssen Company Summary
7.3.2 Janssen Business Overview
7.3.3 Janssen Proton Pump Inhibitors (PPIs) Major Product Offerings
7.3.4 Janssen Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.3.5 Janssen Key News & Latest Developments
7.4 Eisai
7.4.1 Eisai Company Summary
7.4.2 Eisai Business Overview
7.4.3 Eisai Proton Pump Inhibitors (PPIs) Major Product Offerings
7.4.4 Eisai Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.4.5 Eisai Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Proton Pump Inhibitors (PPIs) Major Product Offerings
7.5.4 Eli Lilly Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 Cadila Pharmaceuticals
7.6.1 Cadila Pharmaceuticals Company Summary
7.6.2 Cadila Pharmaceuticals Business Overview
7.6.3 Cadila Pharmaceuticals Proton Pump Inhibitors (PPIs) Major Product Offerings
7.6.4 Cadila Pharmaceuticals Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.6.5 Cadila Pharmaceuticals Key News & Latest Developments
7.7 Santarus
7.7.1 Santarus Company Summary
7.7.2 Santarus Business Overview
7.7.3 Santarus Proton Pump Inhibitors (PPIs) Major Product Offerings
7.7.4 Santarus Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.7.5 Santarus Key News & Latest Developments
7.8 Wyeth
7.8.1 Wyeth Company Summary
7.8.2 Wyeth Business Overview
7.8.3 Wyeth Proton Pump Inhibitors (PPIs) Major Product Offerings
7.8.4 Wyeth Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.8.5 Wyeth Key News & Latest Developments
7.9 Changzhou Siyao Pharmaceuticals
7.9.1 Changzhou Siyao Pharmaceuticals Company Summary
7.9.2 Changzhou Siyao Pharmaceuticals Business Overview
7.9.3 Changzhou Siyao Pharmaceuticals Proton Pump Inhibitors (PPIs) Major Product Offerings
7.9.4 Changzhou Siyao Pharmaceuticals Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.9.5 Changzhou Siyao Pharmaceuticals Key News & Latest Developments
7.10 Yangzhou Pharmaceutical
7.10.1 Yangzhou Pharmaceutical Company Summary
7.10.2 Yangzhou Pharmaceutical Business Overview
7.10.3 Yangzhou Pharmaceutical Proton Pump Inhibitors (PPIs) Major Product Offerings
7.10.4 Yangzhou Pharmaceutical Proton Pump Inhibitors (PPIs) Sales and Revenue in Global (2018-2023)
7.10.5 Yangzhou Pharmaceutical Key News & Latest Developments
8 Global Proton Pump Inhibitors (PPIs) Production Capacity, Analysis
8.1 Global Proton Pump Inhibitors (PPIs) Production Capacity, 2018-2029
8.2 Proton Pump Inhibitors (PPIs) Production Capacity of Key Manufacturers in Global Market
8.3 Global Proton Pump Inhibitors (PPIs) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Proton Pump Inhibitors (PPIs) Supply Chain Analysis
10.1 Proton Pump Inhibitors (PPIs) Industry Value Chain
10.2 Proton Pump Inhibitors (PPIs) Upstream Market
10.3 Proton Pump Inhibitors (PPIs) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Proton Pump Inhibitors (PPIs) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMG23LY8614 )"プロトンポンプ阻害剤(PPI)のグローバル市場展望 2023年-2029年:パントプラゾール、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、その他" (英文:Proton Pump Inhibitors (PPIs) Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。